Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ohashi, Yasuo"" wg kryterium: Autor


Tytuł :
Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial.
Autorzy :
Hagiwara Y; Department of Biostatistics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. .
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Uemura Y; Biostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Kawahara T; Biostatistics Division, Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
Shimozuma K; Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Takahashi M; Department of Breast Surgery, NHO Hokkaido Cancer Center, Sapporo, Japan.
Saito T; Department of Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
Baba S; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
Kobayashi K; Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jun 02. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors.
Autorzy :
Goto A; Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan.
Go H; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Miyakawa K; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yamaoka Y; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Life Science Laboratory, Technology and Development Division, Kanto Chemical Co, Inc., Kanagawa, Japan.
Ohtake N; Bioscience Division, Research and Development Department, Tosoh Corporation, Tokyo Research Center, Kanagawa, Japan.; Advanced Medical Research Center, Yokohama City University, Yokohama, Japan.
Kubo S; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Jeremiah SS; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Mihara T; Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan.
Senuki K; YCU Center for Novel and Exploratory Clinical Trials, Yokohama City University Hospital, Yokohama, Japan.
Miyazaki T; Department of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Kato H; Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan.
Matsuba I; Matsuba Medical Clinic, Kanagawa, Japan.
Sanno N; Sanno Clinic Shinagawa, Tokyo, Japan.
Miyakawa M; Japan Medical Association, Tokyo, Japan.
Ozaki H; Tokyo Medical Association, Tokyo, Japan.
Kikuoka M; Kanagawa Prefecture Medical Association, Yokohama, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Ryo A; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yamanaka T; Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan.; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pokaż więcej
Źródło :
Frontiers in microbiology [Front Microbiol] 2021 May 07; Vol. 12, pp. 661187. Date of Electronic Publication: 2021 May 07 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial.
Autorzy :
Yokomizo A; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Koga H; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Ito K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Takezawa Y; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
Komiyama M; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
Yonese J; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
Hashine K; Department of Urology, Shikoku Cancer Center, Matsuyama, Japan.
Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Arai G; Department of Urology, Dokkyo University Koshigaya Hospital, Koshigaya, Japan.
Saito S; Department of Urology, Tokyo Medical Center, Tokyo, Japan.
Shinohara M; Department of Urology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Shimizu N; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
Yamauchi A; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Satoh T; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Tochigi T; Department of Urology, Miyagi Cancer Center, Natori, Japan.
Kobayashi M; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
Fujimoto H; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Kakimoto KI; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
Fukui I; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
Tsukamoto T; Sapporo Medical University School of Medicine, Sapporo, Japan.
Nozaki M; Department of Radiation Oncology, Dokkyo University Koshigaya Hospital, Koshigaya, Japan.
Karasawa K; Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Hasumi M; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
Ohtani M; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Ishiyama H; Department of Radiation and Radiation Oncology, Kitasato University, Sagamihara, Japan.
Kuwahara M; Sendai Jin-hinyokika, Sendai, Japan.
Harada M; Kanagawa Cancer Center, Yokohama, Japan.
Ohashi Y; University of Tokyo, Tokyo, Japan.
Kotake T; Kotake Clinic, Osaka, Japan.
Kakizoe T; President, Japan Cancer Society, Tokyo, Japan.
Suzuki K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Naito S; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.
Yamanaka H; Institute for Preventive Medicine, Kurosawa Hospital, Takasaki, Japan.
Pokaż więcej
Corporate Authors :
National Research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators
Źródło :
Cancer medicine [Cancer Med] 2021 May; Vol. 10 (10), pp. 3240-3248. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.
Autorzy :
Kurebayashi J; Department of Breast and Thyroid Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan. .
Shiba E; Department of Breast Surgery, Osaka Breast Clinic, 1-13-8 Ohiraki, Osaka Fukushima-ku, Osaka, 553-0007, Japan.
Toyama T; Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya-shi, Aichi, 467-8602, Japan.
Matsumoto H; Division of Breast Surgery, Saitama Cancer Center, 780 Komuro, Ina-machi, Kitaadachi-gun, Saitama, 362-0806, Japan.
Okazaki M; Division of Breast Surgery, Sapporo Breast Surgical Clinic, 19-22-6 Kita 6-jonishi, Sapporo Chuo-ku, Hokkaido, 060-0006, Japan.
Nomizu T; Department of Surgery, Hoshi General Hospital, 159-1 Mukaigawaramachi, Koriyama-shi, Fukushima, 963-8501, Japan.
Ohtake T; Department of Breast Surgery, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima-City, Fukushima, 960-1295, Japan.
Fujii T; Division of Breast and Endocrine Surgery, Gunma University Hospital, 3-39-15 Showamachi, Maebashi-shi, Gunma, 371-8511, Japan.
Ohashi Y; Department of Integrated Science and Technology, Chuo University, 1-13-27 Kasuga, Bunkyo-ku, TokyoTokyo, 112-8551, Japan.
Pokaż więcej
Źródło :
Breast cancer (Tokyo, Japan) [Breast Cancer] 2021 May; Vol. 28 (3), pp. 684-697. Date of Electronic Publication: 2021 Feb 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multicenter open-label randomized controlled study.
Autorzy :
Tsuruya K; Department of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan. .
Hayashi T; Department of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan.
Yamamoto H; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Hase H; Aoba Hospital, Tokyo, Japan.
Nishi S; Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, Kobe, Japan.
Yamagata K; Division of Clinical Medicine, Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Wada T; Department of Nephrology and Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Uemura Y; Biostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Hirakata H; Fukuoka Renal Clinic, Fukuoka, Japan.
Pokaż więcej
Corporate Authors :
RADIANCE-CKD Study Investigators
Źródło :
Clinical and experimental nephrology [Clin Exp Nephrol] 2021 May; Vol. 25 (5), pp. 456-466. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study.
Autorzy :
Sasako T; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ueki K; Department of Molecular Diabetic Medicine, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.
Miyake K; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Okazaki Y; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takeuchi Y; Toranomon Hospital Endocrine Center, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Noda M; Ichikawa Hospital, International University of Health and Welfare, Ichikawa, Japan.; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
Kadowaki T; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Toranomon Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2021 Apr 23; Vol. 106 (5), pp. e2116-e2128.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Functional categories based on cognition and activities of daily living predict all-cause mortality in older adults with diabetes mellitus: The Japanese Elderly Diabetes Intervention Trial.
Autorzy :
Omura T; Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Tamura Y; Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Sakurai T; The Center for Comprehensive Care and Research on Demented Disorders, National Center for Geriatrics and Gerontology, Obu, Japan.
Umegaki H; Department of Geriatrics and Community Healthcare, Graduate School of Medicine, University of Nagoya, Nagoya, Japan.
Iimuro S; Innovation and Research Support Center, International University of Health and Welfare, Tokyo, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Ito H; Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Araki A; Department of Diabetes, Metabolism and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
Japanese Elderly Diabetes Intervention Trial Research Group
Źródło :
Geriatrics & gerontology international [Geriatr Gerontol Int] 2021 Apr 22. Date of Electronic Publication: 2021 Apr 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer.
Autorzy :
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Uemura Y; Biostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Saito T; Department of Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
Baba S; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
Kobayashi K; Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Kawashima H; Department of Surgery, Aomori City Hospital, Aomori, Japan.
Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan.
Sagawa N; Department of Breast Surgery, Kameda Medical Center, Kamogawa, Japan.
Bando H; Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Takahashi M; Department of Breast Surgery, NHO Hokkaido Cancer Center, Sapporo, Japan.
Yamaguchi M; Department of Breast Surgery, JCHO Kurume General Hospital, Kurume, Japan.
Takashima T; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Nakayama T; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan.
Kashiwaba M; Department of Breast Surgery, Adachi Breast Clinic, Kyoto, Japan.
Mizuno T; Department of Medical Oncology, Mie University Hospital, Tsu, Japan.
Yamamoto Y; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Kawahara T; Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
RESPECT Study Group
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Apr 09, pp. JCO2002751. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia.
Autorzy :
Izutsu K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Kinoshita T; Department of Hematology/Cell Therapy, Aichi Cancer Center, Nagoya-shi, Japan.
Takizawa J; Department of Hematology/Endocrinology/Metabolism, Faculty of Medicine, Niigata University, Niigata-shi, Japan.
Fukuhara S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Ohashi Y; Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
Suzumiya J; Innovative Cancer Center/Oncology-Hematology, Shimane University Hospital, Izumo-shi, Japan.
Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2021 Mar 03; Vol. 51 (3), pp. 408-415.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Cyclophosphamide/*therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Rituximab/*therapeutic use
Vidarabine/*analogs & derivatives
Aged ; Antibodies, Neoplasm/immunology ; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics ; Area Under Curve ; Cyclophosphamide/adverse effects ; Cyclophosphamide/pharmacokinetics ; Disease Progression ; Endpoint Determination ; Female ; Humans ; Immunosuppression ; Japan ; Leukemia, Lymphocytic, Chronic, B-Cell/blood ; Leukemia, Lymphocytic, Chronic, B-Cell/immunology ; Male ; Middle Aged ; Remission Induction ; Rituximab/adverse effects ; Rituximab/blood ; Rituximab/pharmacokinetics ; Treatment Outcome ; Vidarabine/adverse effects ; Vidarabine/pharmacokinetics ; Vidarabine/therapeutic use
Czasopismo naukowe
Tytuł :
A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
Autorzy :
Takashima T; Osaka City University Graduate School of Medicine, Osaka, Japan.
Hara F; Cancer Institute Hospital of JFCR, Tokyo, Japan.
Iwamoto T; Okayama University Hospital, Okayama, Japan. Electronic address: .
Uemura Y; National Center for Global Health and Medicine, Tokyo, Japan.
Ohsumi S; NHO Shikoku Cancer Center, Matsuyama, Japan.
Yotsumoto D; Sagara Hospital Miyazaki, Social Medical Corporation Miyazaki Hakuaikai, Miyazaki, Japan.
Hozumi Y; University of Tsukuba Hospital, Tsukuba/Ibaraki Prefectural Central Hospital, Kasama, Japan.
Watanabe T; NHO Sendai Medical Center, Sendai, Japan.
Saito T; Japanese Red Cross Saitama Hospital, Saitama, Japan.
Watanabe KI; NHO Hokkaido Cancer Center, Hokkaido, Japan.
Tsurutani J; Showa University, Tokyo, Japan.
Toyama T; Nagoya City University Hospital, Nagoya, Japan.
Akabane H; Hokkaido P.W.F.A.C. Asahikawa-Kosei General Hospital, Asahikawa, Japan.
Nishimura R; Kumamoto Shinto General Hospital, Kumamoto, Japan.
Taira N; Okayama University Hospital, Okayama, Japan.
Ohashi Y; Chuo University, Tokyo, Japan.
Mukai H; National Cancer Center Hospital East, Kashiwa, Japan.
Pokaż więcej
Źródło :
Clinical breast cancer [Clin Breast Cancer] 2021 Feb 01. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).
Autorzy :
Ohno S; Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. .
Saji S; Fukushima Medical University, Fukushima, Japan.
Masuda N; National Hospital Organization Osaka National Hospital, Osaka, Japan.
Tsuda H; National Defense Medical College, Saitama, Japan.
Akiyama F; Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Kurosumi M; Kameda Medical Center, Chiba, Japan.
Shimomura A; National Cancer Center Hospital, Tokyo, Japan.
Sato N; Niigata Cancer Center Hospital, Niigata, Japan.
Takao S; Hyogo Cancer Center, Hyogo, Japan.
Ohsumi S; NHO Shikoku Cancer Center, Ehime, Japan.
Tokuda Y; Tokai University School of Medicine, Kanagawa, Japan.
Inaji H; Kaizuka City Hospital, Osaka, Japan.
Watanabe T; Hamamatsu Oncology Center, Shizuoka, Japan.
Ohashi Y; Chuo University, Tokyo, Japan.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Feb; Vol. 186 (1), pp. 135-147. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.
Autorzy :
Omote K; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
Yokota I; Department of Biostatistics, Graduate School of Medicine, Hokkaido University.
Nagai T; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
Sakuma I; Caress Sapporo Hokko Memorial Clinic.
Nakagawa Y; Department of Cardiovascular Medicine, Shiga University of Medical Science Hospital.
Kamiya K; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
Iwata H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.
Miyauchi K; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.
Ozaki Y; Department of Cardiology, Fujita Health University School of Medicine.
Hibi K; Division of Cardiology, Yokohama City University Medical Center.
Hiro T; Division of Cardiology, Department of Medicine, Nihon University School of Medicine.
Fukumoto Y; Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine.
Mori H; Department of Cardiology, Showa University Fujigaoka Hospital.
Hokimoto S; Department of Cardiovascular Medicine, Kumamoto University Hospital.
Ohashi Y; Department of Integrated Science and Technology for Sustainable Society, Chuo University.
Ohtsu H; National Center for Global Health and Medicine, Center for Clinical Sciences.
Ogawa H; National Cerebral and Cardiovascular Center.
Daida H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.
Iimuro S; Teikyo Academic Research Center, Teikyo University.
Shimokawa H; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine.
Saito Y; Chiba University.
Kimura T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine.
Matsuzaki M; St. Hill Hospital.
Nagai R; Jichi Medical University.
Anzai T; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
Pokaż więcej
Corporate Authors :
REAL-CAD study investigators
Źródło :
Journal of atherosclerosis and thrombosis [J Atheroscler Thromb] 2021 Jan 09. Date of Electronic Publication: 2021 Jan 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes.
Autorzy :
Ueki K; Department of Molecular Diabetic Medicine, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.
Sasako T; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Okazaki Y; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Miyake K; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Nangaku M; Department of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Noda M; Department of Diabetes, Metabolism and Endocrinology, Ichikawa Hospital, International University of Health and Welfare, Chiba, Japan; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
Kadowaki T; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Toranomon Hospital, Tokyo, Japan. Electronic address: .
Pokaż więcej
Corporate Authors :
J-DOIT3 Study Group
Źródło :
Kidney international [Kidney Int] 2021 Jan; Vol. 99 (1), pp. 256-266. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Autorzy :
Toi M; Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto, Japan. Electronic address: .
Imoto S; Kyorin University Hospital, Mitaka, Japan.
Ishida T; Tohoku University, Sendai, Japan.
Ito Y; Cancer Institute Hospital, Tokyo, Japan.
Iwata H; Aichi Cancer Center Hospital, Nagoya, Japan.
Masuda N; National Hospital Organization Osaka National Hospital, Osaka, Japan.
Mukai H; National Cancer Center Hospital East, Kashiwa, Japan.
Saji S; Fukushima Medical University, Fukushima, Japan.
Shimizu A; Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto, Japan.
Ikeda T; Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto, Japan.
Haga H; Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto, Japan.
Saeki T; Saitama Medical University International Medical Center, Hidaka, Japan.
Aogi K; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Sugie T; Kansai Medical University Hospital, Hirakata, Japan.
Ueno T; Cancer Institute Hospital, Tokyo, Japan.
Kinoshita T; National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Kai Y; Ueo Breast Surgery Clinic, Oita, Japan.
Kitada M; Asahikawa Medical University Hospital, Asahikawa, Japan.
Sato Y; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Jimbo K; National Cancer Center Hospital, Tokyo, Japan.
Sato N; Niigata Cancer Center Hospital, Niigata, Japan.
Ishiguro H; International University of Health and Welfare Narita Hospital, Narita, Japan.
Takada M; Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto, Japan.
Ohashi Y; Chuo University, Tokyo, Japan.
Ohno S; Cancer Institute Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2021 Jan; Vol. 22 (1), pp. 74-84.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Aromatase Inhibitors/*administration & dosage
Biomarkers, Tumor/*analysis
Breast Neoplasms/*drug therapy
Oxonic Acid/*administration & dosage
Receptor, ErbB-2/*analysis
Receptors, Estrogen/*analysis
Selective Estrogen Receptor Modulators/*administration & dosage
Tegafur/*administration & dosage
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aromatase Inhibitors/adverse effects ; Breast Neoplasms/chemistry ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Drug Combinations ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Oxonic Acid/adverse effects ; Selective Estrogen Receptor Modulators/adverse effects ; Tegafur/adverse effects ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.
Autorzy :
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Uemura Y; Biostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Saito T; Department of Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
Baba S; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
Kobayashi K; Department of Medical Oncology, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Kawashima H; Department of Surgery, Aomori City Hospital, Aomori, Japan.
Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan.
Sagawa N; Department of Breast Surgery, Kameda Medical Center, Kamogawa, Japan.
Bando H; Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
Yamaguchi M; Department of Breast Surgery, JCHO Kurume General Hospital, Kurume, Japan.
Takashima T; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Nakayama T; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka Japan.
Kashiwaba M; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
Mizuno T; Department of Medical Oncology, Mie University Hospital, Tsu, Japan.
Yamamoto Y; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Kawahara T; Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Pokaż więcej
Corporate Authors :
RESPECT study group
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 10; Vol. 38 (32), pp. 3743-3752. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Receptor, ErbB-2/*metabolism
Trastuzumab/*therapeutic use
Age Factors ; Aged ; Aged, 80 and over ; Breast Neoplasms/enzymology ; Breast Neoplasms/pathology ; Cyclophosphamide/administration & dosage ; Disease-Free Survival ; Docetaxel/administration & dosage ; Doxorubicin/administration & dosage ; Epirubicin/administration & dosage ; Female ; Humans ; Neoplasm Staging ; Quality of Life ; Survival Rate ; Trastuzumab/administration & dosage
Czasopismo naukowe
Tytuł :
Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women.
Autorzy :
Shiko Y; Biostatistics Section, Clinical Research Center, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
Konno R; Department of Obstetrics and Gynecology, Jichi Medical University Saitama Medical Center, Omiya-ku, Saitama, 330-8530, Japan. .
Konishi H; Japan Cancer Society, Tokyo, Japan.
Sauvaget C; Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer (WHO), Lyon, France.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Kakizoe T; Japan Cancer Society, Tokyo, Japan.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Nov 05; Vol. 20 (1), pp. 808. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :
Journal Article
MeSH Terms :
Vaccination*
Cervical Intraepithelial Neoplasia/*prevention & control
Papillomaviridae/*immunology
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*immunology
Uterine Cervical Neoplasms/*prevention & control
Adult ; Cervical Intraepithelial Neoplasia/classification ; Cervical Intraepithelial Neoplasia/virology ; Cross-Sectional Studies ; Female ; Humans ; Immunization Programs ; Incidence ; Japan/epidemiology ; Papillomavirus Infections/epidemiology ; Papillomavirus Vaccines/administration & dosage ; Prevalence ; Treatment Outcome ; Uterine Cervical Neoplasms/classification ; Uterine Cervical Neoplasms/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Corrigendum to: Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry.
Autorzy :
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Ikeda M; Division of Lower Gastrointestinal Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Kunitoh H; Department of Medical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan.
Sasako M; Department of Surgery, Yodogawa Christian Hospital, Osaka, Japan.
Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Mukai H; Division of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Fujiwara K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
Nakamura M; Department of Internal Medicine, Pediatrics and Cardiology, Nakamura Medical Clinic, Kuwana, Japan.
Oba MS; Department of Medical Statistics, Faculty of Medicine, Toho University, Tokyo, Japan.
Kimura T; Medical Science Department, Daiichi Sankyo Co. Ltd., Tokyo, Japan.
Ibusuki K; Medical Science Department, Daiichi Sankyo Co. Ltd., Tokyo, Japan.
Sakon M; Department of Gastrointestinal Surgery, Osaka International Cancer Institute, Osaka, Japan.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2020 Oct 22; Vol. 50 (11), pp. 1346.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry.
Autorzy :
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Ikeda M; Division of Lower Gastrointestinal Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Kunitoh H; Department of Medical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan.
Sasako M; Department of Surgery, Yodogawa Christian Hospital, Osaka, Japan.
Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Mukai H; Division of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Fujiwara K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
Nakamura M; Department of Internal Medicine, Pediatrics and Cardiology, Nakamura Medical Clinic, Kuwana, Japan.
Oba MS; Department of Medical Statistics, Faculty of Medicine, Toho University, Tokyo, Japan.
Kimura T; Medical Science Department, Daiichi Sankyo Co. Ltd., Tokyo, Japan.
Ibusuki K; Medical Science Department, Daiichi Sankyo Co. Ltd., Tokyo, Japan.
Sakon M; Department of Gastrointestinal Surgery, Osaka International Cancer Institute, Osaka, Japan.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2020 Oct 22; Vol. 50 (11), pp. 1246-1253.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Registries*
Research Report*
Neoplasms/*complications
Venous Thromboembolism/*complications
Venous Thromboembolism/*epidemiology
Aged ; Female ; Humans ; Male ; Neoplasm Staging ; Prevalence ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial.
Autorzy :
Ito K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.; Institute for Preventive Medicine, Kurosawa Hospital, Takasaki, Japan.
Kobayashi M; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
Komiyama M; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Naito S; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
Yonese J; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
Hashine K; Department of Urology, Shikoku Cancer Center, Matsuyama, Japan.
Saito S; Department of Urology, Tokyo Medical Center, Tokyo, Japan.
Arai G; Department of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Shinohara M; Department of Urology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Shimizu N; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
Satoh T; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Yamauchi A; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Tochigi T; Department of Urology, Miyagi Cancer Center, Natori, Japan.
Takezawa Y; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
Fujimoto H; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Yokomizo A; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Kakimoto KI; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
Fukui I; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
Karasawa K; Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Tsukamoto T; Sapporo Medical University School of Medicine, Sapporo, Japan.
Nozaki M; Department of Radiation Oncology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Hasumi M; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
Ishiyama H; Department of Radiation and Radiation Oncology, Kitasato University, Sagamihara, Japan.
Ohtani M; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Kuwahara M; Sendai Jin-Hinyokika, Sendai, Japan.
Harada M; Kanagawa Cancer Center, Yokohama, Japan.
Ohashi Y; University of Tokyo, Tokyo, Japan.
Kotake T; Kotake Clinic, Osaka, Japan.
Kakizoe T; Japan Society for Cancer, Tokyo, Japan.
Suzuki K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Yamanaka H; Institute for Preventive Medicine, Kurosawa Hospital, Takasaki, Japan.
Pokaż więcej
Corporate Authors :
National Research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer Investigators
Źródło :
Cancer [Cancer] 2020 Sep 01; Vol. 126 (17), pp. 3961-3971. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Androgen Antagonists/*administration & dosage
Neoadjuvant Therapy/*adverse effects
Neoplasm Recurrence, Local/*drug therapy
Prostatic Neoplasms/*drug therapy
Aged ; Androgen Antagonists/adverse effects ; Combined Modality Therapy ; Disease-Free Survival ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Proportional Hazards Models ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy ; Radiotherapy, Conformal/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer.
Autorzy :
Ohsumi S; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minami-umemoto-machi, Matsuyama 791-0280, Japan.
Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa.
Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo.
Hozumi Y; Department of Breast Surgery, Ibaraki Prefectural Central Hospital, Kasama.
Akabane H; Department of Surgery, Asahikawa-kosei General Hospital, Asahikawa.
Park Y; Department of Breast and Endocrine Surgery, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai.
Tokunaga E; Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka.
Takashima T; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka.
Watanabe T; Department of Breast Surgery, National Hospital Organization Sendai Medical Center, Sendai.
Sagara Y; Department of Breast Oncology, Hakuaikai Medical Corp Sagara Hospital, Kagoshima.
Kaneko T; Department of Clinical Research, Tokyo Metropolitan Children's Medical Center, Fuchu.
Ohashi Y; Faculty of Science and Engineering, Chuo University, Tokyo.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2020 Aug 04; Vol. 50 (8), pp. 873-881.
Typ publikacji :
Journal Article
MeSH Terms :
Randomized Controlled Trials as Topic*
Breast Neoplasms/*pathology
Adult ; Female ; Humans ; Informed Consent ; Middle Aged ; Prospective Studies ; Surveys and Questionnaires
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies